Dr Thangaraj Devadoss

Associate Professor

Qualification: M. S. (Pharm.), Ph.D.

Specialization: Pharmaceutical Chemistry

Email ID: thangaraj.devadoss@svkm.ac.in

Phone: +91 9492988619

Experience: 11 Years

30.10.17 to 23.08.2022: Associate Professor, KVSR Siddhartha College of Pharmaceutical Sciences, Vijayawada, India

22.05.2017 to 27.10.2017: Associate Professor, Sree Vidyanikethan College of Pharmacy, Tirupati, India.

28.09.2015 to 20.12.2016: Lecturer-III, International Medical University, Kuala Lumpur, Malaysia.

10.09.2012 to 10.09.2015: Assistant Professor, KVSR Siddhartha College of Pharmaceutical Sciences, Vijayawada, India

02.01.2012 to 05.09.2012: Associate Professor, Creative Educational Society’s College of Pharmacy, Kurnool, India.

04.10.2006 to 13.08.2007: Lecturer, Jaya College of Paramedical Sciences, Chennai, India.

18.01.2006 to 30.09.2006: Trainee Medicinal Chemist, Orchid Chemicals and Pharmaceuticals (P) Ltd., Chennai, India.

Interest Areas: Medicinal Chemistry and Organic Chemistry

Research:

• Publications:
  • International: 22
  • National: 15
• Books: Nil
• Book Chapters: Nil
• Patents: Nil
• Presentations:
  • International: Nil
  • National: 3
• Completed Government Funded Projects: Nil
• Industry Projects:
  • Completed: Nil
  • Ongoing: Nil

Conferences/Workshops/Seminars attended: 30

Academic Activities:

• Ph.D.
  • Awarded (Nil)
  • Registered: Nil
• M. Pharm Guided: 9
• B. Pharm Guided: 6 Projects

Awards:

• Qualified with 25th rank at all India level in NIPER entrance examination-2003
• Secured 97.84 percentile with 133rd rank at all India level in GATE examination-2003
• Project Fellow: 2007-2010: UGC sponsored Project-New Delhi, India

Professional Membership:

• Registered Life time Pharmacist at Tamil Nadu State Pharmacy Council

Recent Publications:

1. Thangaraj Devadoss, Veldhi Sowmya, Ravali Bastati, Synthesis of 1,6-Naphthyridine and Its Derivatives: A Systematic Review, ChemistrySelect, 6, 2021, (Impact factor 2.307).

2. Shvetank Bhatt, Thangaraj Devadoss, Santhepete Nanjundaiah Manjula, Jayaraman Rajangam, 5-HT3 receptor antagonism a potential therapeutic approach for the treatment of depression and other disorders, Current Neuropharmacology, 19, 2021 (Impact factor 7.708).

3. Radhakrishnan Mahesh, Sourabh Mundra, Thangaraj Devadoss, Lakshmi P. Kotra, Design, synthesis and evaluation of 2-(4-(substituted benzoyl)-1,4-diazepan-1-yl)-N-phenylacetamide derivatives as a new class of falcipain-2 inhibitors, Arabian Journal of Chemistry, 12, 2019 (Impact factor: 6.212)

4. Murugesh Kandasamy, Kit-Kay Mak, Thangaraj Devadoss, Punniyakoti Veeraveedu Thanikachalam, Raghavendra Sakirolla, Hira Choudhury, Mallikarjuna Rao Pichika, Construction of a novel quinoxaline as a new class of Nrf2 activator, BMC Chemistry, 13, 2019, (Impact factor: 2.094).

5. Yeshwant Kurhe, Radhakrishnan Mahesh, Thangaraj Devadoss, Novel 5-HT3 receptor antagonist QCM-4 attenuates depressive-like phenotype associated with obesity in high-fat-diet-fed mice, Psychopharmacology, 234, 2017 (Impact factor: 4.415).